Scientists analyze HIV drug levels in kids to improve dosing
NCT ID NCT03194165
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study examined blood samples from 65 children aged 0 to 18 who were taking common HIV medications. The goal was to create computer models that show how these drugs behave in children, helping doctors adjust doses for each child's age, weight, and other factors. The research did not test new drugs but aimed to make existing treatments safer and more effective for kids.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- antiretroviral drugs (dolutegravir, raltegravir, rilpivirine, nevirapine, atazanavir, darunavir, ritonavir)
- What this could lead to
- If successful, this could help doctors give more accurate doses of HIV medicines to children based on age, weight, and other factors.
- What could go wrong
- This is a small, completed study that only looked at existing blood test data. It does not test a new treatment, so any dosing recommendations would need further validation.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cochin Hospital
Paris, Paris, 75014, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new strategy break the cycle of HIV care dropout?
- A One-Two punch against cervical cancer: testing plus vaccination in HIV-Positive women
- Smart pill bottles and health coaches team up to tackle HIV in the deep south
- Can one Mega-Dose of an antifungal beat a deadly infection in AIDS patients?
- Can Long-Acting HIV shots outperform daily pills during lymphoma treatment?
- Immune-Boosting cocktail aims to free HIV patients from daily medication